Effects of a Nitric Oxide Synthase Inhibitor on Prostaglandin-Induced Aqueous Flare Elevation in Pigmented Rabbits

Ophthalmic Research

Volumn 28, Issue 4, 1996, Pages 260-264

  Hiraki, Shigeyoshi ^a   Zhang, Xue Yun ^a   Hayasaka, Seiji ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Aqueous flare; Nitric oxide synthase inhibitor; Pigmented rabbits; Prostaglandins

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; EYE INFLAMMATION; LASER FLARE CELL METER; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION;

ANIMALS; AQUEOUS HUMOR; BLOOD-AQUEOUS BARRIER; CAPILLARY PERMEABILITY; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EYE PROTEINS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPHTHALMIC SOLUTIONS; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; RABBITS;

EID: 0029791489     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000267912     Document Type: Article

References (14)

1. Ncufcld AH, Scars ML: The site of prostaglandin E2 on the disruption of the blood-aqueous barrier in the rabbit eye, Exp Eye Res 1973; 17: 445-448.
2. Kulkarni PS, Srinivasan BD: The effect of intravitreal and topical prostaglandins on intraocular inflammation, Invest Ophthalmol Vis Sci 1982;23:383-392.
3. Kaji Y, lliraki S, Hirata H: The effect of calcium antagonists 011 prostaglandin E reaction in rabbit eyes, J Jpn Ophthalmol Soc 1994; 98:825-831.
4. Hirata H, Hiraki S, Kaji Y, Takeda N, Fukuo Y, Tachinami K: The effect of transcorncal administration of prostaglandin E; on rabbit eyes, J Jpn Ophthalmol Soc 1994:98:927-934.
5. Parks DJ, Cheung MK, Chan CC, Roberge FG: The role of nitric oxide in uveitis, Arch Ophthalmol 1994: 112:544-546.
6. Astin M, Stjernschantz J, Sclen G: Role of nitric oxide in PGF^-in-duced ocular hyperemia, Exp Eye Res 1994;59:401-408.
7. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD: Nitric oxide and choroidal blood flow regulation, Invest Ophthalmol Vis Sci 1995;36:925-930.
8. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo, Br J Pharmacol 1990: 101:746-752.
9. Sawa M, Tsurimaki Y, Tsuru T, Shimizu H: New quantitative method to determine protein concentration and cell number in aqueous in vivo, Jpn J Ophthalmol 1988:32: 132-142.
10. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol Rev 1991;43:109-142.
11. 2+ selectively suppresses II,-1-induced NO production by reducing iNOS ntRNA stability, J Cell Biol 1995;129:1651-1657.
12. Radontski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells, Proc Natl Acad Sci USA 1990:87: 10043-10047.
13. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needle-man P: Nitric oxide activates cy-clooxygenase enzymes, Proc Natl Acad Sci USA 1993;90:7240-7244.
14. Nathanson JA: Nitric oxide and ni-trovasodilators in the eye: Implications for ocular physiology and glaucoma, J Glaucoma 1993:2:106-210.